These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1086 related articles for article (PubMed ID: 18552276)

  • 1. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets.
    Takabe K; Paugh SW; Milstien S; Spiegel S
    Pharmacol Rev; 2008 Jun; 60(2):181-95. PubMed ID: 18552276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting sphingosine-1-phosphate in hematologic malignancies.
    Stevenson CE; Takabe K; Nagahashi M; Milstien S; Spiegel S
    Anticancer Agents Med Chem; 2011 Nov; 11(9):794-8. PubMed ID: 21707492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
    Brinkmann V
    Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progress of the selective sphingosine-1-phosphate receptor 1 agonists].
    Tian YL; Jin J; Wang XJ
    Yao Xue Xue Bao; 2012 Jan; 47(1):7-17. PubMed ID: 22493799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of sphingosine 1-phosphate on functions of T cell - review].
    Huang WR; Wang LS; DA WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):718-22. PubMed ID: 16129068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine and paracrine roles of sphingosine-1-phosphate.
    Alvarez SE; Milstien S; Spiegel S
    Trends Endocrinol Metab; 2007 Oct; 18(8):300-7. PubMed ID: 17904858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targets of FTY720 (fingolimod).
    Pitman MR; Woodcock JM; Lopez AF; Pitson SM
    Curr Mol Med; 2012 Dec; 12(10):1207-19. PubMed ID: 22834825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
    Huwiler A; Pfeilschifter J
    Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema.
    Diab KJ; Adamowicz JJ; Kamocki K; Rush NI; Garrison J; Gu Y; Schweitzer KS; Skobeleva A; Rajashekhar G; Hubbard WC; Berdyshev EV; Petrache I
    Am J Respir Crit Care Med; 2010 Feb; 181(4):344-52. PubMed ID: 19965812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.
    Natarajan V; Dudek SM; Jacobson JR; Moreno-Vinasco L; Huang LS; Abassi T; Mathew B; Zhao Y; Wang L; Bittman R; Weichselbaum R; Berdyshev E; Garcia JG
    Am J Respir Cell Mol Biol; 2013 Jul; 49(1):6-17. PubMed ID: 23449739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.
    Huwiler A; Pfeilschifter J
    Biochem Pharmacol; 2008 May; 75(10):1893-900. PubMed ID: 18321471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine 1-phosphate in coagulation and inflammation.
    Obinata H; Hla T
    Semin Immunopathol; 2012 Jan; 34(1):73-91. PubMed ID: 21805322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of S1P acting both inside and outside the cells].
    Okada T; Nakamura S
    Seikagaku; 2012 Feb; 84(2):92-101. PubMed ID: 22550899
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
    Butler J; Lana D; Round O; LaMontagne K
    Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of the sphingosine-1-phosphate signalling system.
    Zu Heringdorf DM; Ihlefeld K; Pfeilschifter J
    Handb Exp Pharmacol; 2013; (215):239-53. PubMed ID: 23579459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis.
    Podbielska M; Krotkiewski H; Hogan EL
    Neurochem Res; 2012 Jun; 37(6):1154-69. PubMed ID: 22451227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.
    Brinkmann V
    Pharmacol Ther; 2007 Jul; 115(1):84-105. PubMed ID: 17561264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
    Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effect of S1P receptor modifying drugs for autoimmune diseases].
    Chiba K; Kataoka H
    Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):24-5. PubMed ID: 18421849
    [No Abstract]   [Full Text] [Related]  

  • 20. Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy.
    Groves A; Kihara Y; Chun J
    J Neurol Sci; 2013 May; 328(1-2):9-18. PubMed ID: 23518370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.